Fetal growth after preterm premature rupture of membranes: Is it related to amniotic fluid volume?

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 20, Issue 5, 2007, Pages 397-400

  Deering, Shad H ^a,b   Patel, Neeta ^a   Spong, Catherine Y ^a   Pezzullo, John C ^a   Ghidini, Alessandro ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

Amniotic fluid index; Fetal growth restriction; Preterm premature rupture of membranes

Indexed keywords

ADULT; AMNION FLUID; ANALYSIS OF VARIANCE; ARTICLE; BIOMETRY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DELIVERY; ECHOGRAPHY; FEMALE; FETUS GROWTH; HUMAN; INFANT; OLIGOHYDRAMNIOS; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ABDOMEN; ADULT; AMNIOTIC FLUID; ANTHROPOMETRY; FEMALE; FETAL DEVELOPMENT; FETAL MEMBRANES, PREMATURE RUPTURE; FETUS; GESTATIONAL AGE; HUMANS; PREGNANCY; ULTRASONOGRAPHY, PRENATAL;

EID: 34547663265     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050701280249     Document Type: Article

References (22)

1. Mercer BM, Goldenberg RL, Meiss PJ, Moawad AH, Shellhaas C, Das A, Menard MK, Caritis SN, Thurnau GR, Dombrowski MP, et al. The preterm prediction study: Prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. Am J Obstet Gynecol 2000;183:738-745.
2. Main DM, Gabbe SG, Richardson D, Strong S. Can preterm deliveries be prevented? Am J Obstet Gynecol 1985;151:892-898.
3. Hediger ML, Scholl TO, Schall JI, Miller LW, Fischer RL. Fetal growth and the etiology of preterm delivery. Obstet Gynecol 1995;85:175-182.
4. Beydoun SN, Yasin SY. Premature rupture of the membranes before 28 weeks: Conservative management. Am J Obstet Gynecol 1986;155:471-479.
5. Moretti M, Sibai BM. Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol 1988;159:390-396.
6. Kurzel RB, Lampley EC. Preterm premature rupture of the membranes is associated with asymmetric intrauterine growth retardation and smaller placentas. Prim Care Update Ob Gyns 1998;5:181.
7. Borna S, Borna H, Khazardoost S, Hantoushzadeh S. Perinatal outcome in preterm premature rupture of membranes with amniotic fluid index <5. BMC Pregnancy Childbirth 2004;4:15.
8. Arias F, Rodriguez L, Rayne S, Kraus F. Maternal placental vasculopathy and infection: Two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993;186:585-591.
9. Kim YM, Chaiworapongsa T, Gomez R, Emmanuel B, Yoon BH, Rotmensch S, Thaler HT, Romero R. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002;187:1137-1142.
10. Simpson JL, Palomaki GE, Mercer B, Haddow JE, Andersen R, Sibai B, Elias S. Associations between adverse perinatal outcome and serially obtained second and third trimester maternal serum alpha-fetoprotein measurements. Am J Obstet Gynecol 1995;173:1742-1748.
11. Milunski A, Jick SS, Bruell CL, MacLaughlin DS, Tsung YK, Jick H, Rothman KJ, Willett W. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: New epidemiologic data. Am J Obstet Gynecol 1989;161:291-297.
12. Boyd PA, Keeling JW. Raised maternal serum alpha-fetoprotein in the absence of fetal abnormality - Placental findings. A quantitative morphometric study. Prenat Diagn 1986;6:369-373.
13. Salafia CM, Silberman L, Herrera NE, Mahoney MJ. Placental pathology at term associated with elevated midtrimester serum alpha-fetoprotein concentration. Am J Obstet Gynecol 1988;158:1064-1066.
14. Crandall BF, Robinson L, Grau P. Risk associated with elevated maternal serum alpha-fetoprotein level. Am J Obstet Gynecol 1991;165:581-586.
15. Hamilton MP, Abdalla HI, Whitfield CR. Significance of raised maternal serum alpha-fetoprotein in singleton pregnancies with normal formed fetuses. Obstet Gynecol 1985;65:465-470.
16. Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol 1996;88:816-822.
17. Williams MA, Hickok DE, Zingheim RW, Luthy DA, Kimelman J, Nyberg DA, Mahony BS. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol 1992;167:1032-1037.
18. Ghidini A, Salafia CM, Pezzullo JC. Placental vascular lesions and likelihood of diagnosis of preeclampsia. Obstet Gynecol 1997;90:542-545.
19. Ghidini A. Idiopathic fetal growth restriction: A pathophysiologic approach. Obstet Gynecol Surv 1996;51:376-382.
20. Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH, et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 2005;106:260-267.
21. Spong CY, Ghidini A, Walker CN, Ossandon M, Pezzullo JC. Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia. Am J Obstet Gynecol 1997;177:1085-1087.
22. Perni SC, Chervenak FA, Kalish RB, Magherini-Rothe S, Predanic M, Streltzoff J, Skupski DW. Intraobserver and interobserver reproducibility of fetal biometry. Ultrasound Obstet Gynecol 2004;24:654-658.